2024-11-26 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO):**

Colgate-Palmolive (CL) is a multinational consumer goods company that manufactures and sells oral hygiene, personal care, and household products.  The cumulative return of CL is 47.68%, significantly lagging behind the S&P 500's (VOO) cumulative return of 127.58%.  The difference is -79.9%, placing it at the 7.07th percentile of its historical range of performance relative to the S&P 500 (-86.53% to 7.22%).

**Alpha and Beta Analysis:**

The provided data shows inconsistent performance relative to the market (beta) and alpha (excess return relative to the market). While periods of strong outperformance exist (e.g., 2019-2021), others show significant underperformance or negative alpha.  Market capitalization fluctuates within a relatively narrow range ($48.6B to $77.0B). Maximum drawdown (MDD) consistently remains high, reflecting volatility.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 16.8% | 12.6% | -21.6% | 0.7 | 61.6 |
| 2016-2018  | -1.5% | 14.1% | -33.8% | 0.5 | 48.6 |
| 2017-2019  | 12.8% | 14.1% | -38.9% | 0.5 | 56.2 |
| 2018-2020  | 22.4% | 21.6% | -25.0% | 0.6 | 69.9 |
| 2019-2021  | 54.7% | 21.6% | -45.4% | 0.6 | 69.7 |
| 2020-2022  | 24.1% | 21.6% | 0.5% | 0.6 | 64.4 |
| 2021-2023  | 1.6% | 16.4% | -33.4% | 0.3 | 65.1 |
| 2022-2024  | 20.5% | 16.4% | -9.6% | 0.3 | 77.0 |


**2. Recent Price Movement:**

* **Closing Price:** $94.92 (Last Market: $95.6)
* **5-Day Moving Average:** $94.26
* **20-Day Moving Average:** $93.22
* **60-Day Moving Average:** $99.31

The price is currently below all three moving averages, suggesting a bearish short-term trend.  The recent market price ($95.6) is slightly above the closing price, not indicating significant immediate upward or downward pressure.


**3. Technical Indicators:**

* **RSI (54.55):**  Suggests the stock is neither overbought nor oversold, remaining in a neutral territory.
* **PPO (0.61):** A positive value indicates bullish momentum, although the magnitude is relatively low.
* **20-Day Relative Divergence (-0.81):** Shows a recent weakening in the short-term price trend.


The expected return is 0.0%, meaning no significant outperformance relative to the S&P 500 is predicted over a long-term (2+ years) investment horizon.


**4. Recent Financial Performance:**

The provided data shows relatively stable revenue around $5 billion per quarter, with slight fluctuations. EPS is also relatively consistent, showing a modest growth trend.  There's no information on earnings estimates for comparison.

| Date       | EPS | Revenue       |
|------------|-----|---------------|
| 2024-10-25 | 0.9 | $5.03 B       |
| 2024-07-26 | 0.89 | $5.06 B       |
| 2024-04-26 | 0.83 | $5.07 B       |
| 2023-10-27 | 0.86 | $4.92 B       |
| 2024-10-25 | 0.86 | $4.92 B       |


**6. Financial Ratios:**

**Revenue and Profitability:** Profit margins have remained relatively stable and high, exceeding 60% consistently. Revenue has been steady.

**Capital and Profitability:**  Return on Equity (ROE) shows significant volatility, swinging from extremely high to very low values.  This needs further investigation to understand the underlying factors.  Negative equity in Q3 2023 is a major concern.

**7. News and Recent Issues:**

*  *(This section requires access to real-time news sources such as Shacknews and Finbold.  Information on recent earnings announcements, analyst opinions, and market outlook needs to be gathered from these sources and added here.)*

**8. Summary:**

Colgate-Palmolive (CL) shows consistent revenue and profitability but has significantly underperformed the S&P 500 recently. Technical indicators are neutral.  The highly volatile ROE and instances of negative equity are major red flags requiring further analysis.  A thorough review of recent news, analyst opinions, and any major company developments is crucial before making any investment decisions. The lack of information on expected earnings prevents a complete assessment of future performance.

**9.  Disclaimer:** This report is for informational purposes only and should not be considered investment advice.  Conduct thorough research and consult a financial advisor before making any investment decisions.
